-
Signature
-
/s/ Robert M. Wolfe, as attorney-in-fact
-
Stock symbol
-
VRT
-
Transactions as of
-
Sep 3, 2024
-
Transactions value $
-
-$3,229,706
-
Form type
-
4
-
Date filed
-
9/4/2024, 04:17 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
VRT |
Class A Common Stock |
Options Exercise |
$364K |
+30.2K |
+119.56% |
$12.05 |
55.5K |
Sep 3, 2024 |
Direct |
F1 |
transaction |
VRT |
Class A Common Stock |
Sale |
-$1.01M |
-12.9K |
-23.23% |
$78.08 |
42.6K |
Sep 3, 2024 |
Direct |
F1, F2, F3 |
transaction |
VRT |
Class A Common Stock |
Sale |
-$531K |
-6.7K |
-15.74% |
$79.22 |
35.9K |
Sep 3, 2024 |
Direct |
F1, F2, F4 |
transaction |
VRT |
Class A Common Stock |
Sale |
-$521K |
-6.5K |
-18.12% |
$80.12 |
29.4K |
Sep 3, 2024 |
Direct |
F1, F2, F5 |
transaction |
VRT |
Class A Common Stock |
Sale |
-$800K |
-9.89K |
-33.67% |
$80.89 |
19.5K |
Sep 3, 2024 |
Direct |
F1, F2, F6 |
transaction |
VRT |
Class A Common Stock |
Sale |
-$736K |
-8.95K |
-45.9% |
$82.25 |
10.5K |
Sep 3, 2024 |
Direct |
F1, F2, F7 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
VRT |
Stock Options |
Options Exercise |
$0 |
-30.2K |
-100% |
$0.00 |
0 |
Sep 3, 2024 |
Class A Common Stock |
30.2K |
$12.05 |
Direct |
F8 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: